SEC Form 4 · accession 0001127602-18-009473

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chairman & CEO · Director

Period of report

Feb 28, 2018

Accepted (ET)

Mar 2, 2018 · 7:30 am EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001100682

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Feb 28, 2018	S	600	$107.91	D	314,942	D
Common Stock	Feb 28, 2018	S	100	$107.945	D	314,842	D
Common Stock	Feb 28, 2018	S	100	$107.95	D	314,742	D
Common Stock	Feb 28, 2018	S	100	$107.96	D	314,642	D
Common Stock	Feb 28, 2018	S	32	$107.965	D	314,610	D
Common Stock	Feb 28, 2018	S	200	$107.98	D	314,410	D
Common Stock	Feb 28, 2018	S	100	$107.99	D	314,310	D
Common Stock	Feb 28, 2018	S	68	$107.995	D	314,242	D
Common Stock	Feb 28, 2018	S	100	$108.005	D	314,142	D
Common Stock	Feb 28, 2018	S	191	$108.025	D	313,951	D
Common Stock	Feb 28, 2018	S	609	$108.03	D	313,342	D
Common Stock	Feb 28, 2018	S	100	$108.035	D	313,242	D
Common Stock	Feb 28, 2018	S	500	$108.04	D	312,742	D
Common Stock	Feb 28, 2018	S	194	$108.045	D	312,548	D
Common Stock	Feb 28, 2018	S	100	$108.05	D	312,448	D
Common Stock	Feb 28, 2018	S	106	$108.055	D	312,342	D
Common Stock	Feb 28, 2018	S	200	$108.06	D	312,142	D
Common Stock	Feb 28, 2018	S	400	$108.07	D	311,742	D
Common Stock	Feb 28, 2018	S	100	$108.075	D	311,642	D
Common Stock	Feb 28, 2018	S	300	$108.08	D	311,342	D
Common Stock	Feb 28, 2018	S	300	$108.09	D	311,042	D
Common Stock	Feb 28, 2018	S	100	$108.11	D	310,942	D
Common Stock	Feb 28, 2018	S	302	$108.115	D	310,640	D
Common Stock	Feb 28, 2018	S	200	$108.12	D	310,440	D

No Table II lines on this filing.